PRTC(Delisted)
Puretech Health·NASDAQ
--
--(--)
Puretech Health (PRTC) Company Profile
Puretech Health Plc
A clinical-stage biotherapeutics company that develops products based on insights into the biology of the brain, immune, and gut systems
--
--
11/16/2020
NASDAQ Stock Exchange
56
12-31
Depository Receipts (Ordinary Shares)
6 Tide Street
Suite 400 Boston
Massachusetts 02210 United States
Develops therapeutics for oncology and fibrotic diseases.
Puretech Health Plc is a clinical-stage biotherapeutic company dedicated to discovering, developing and commercializing highly differentiated medicines for destructive diseases, including inflammatory and immune diseases, refractory cancers, lymphatic and gastrointestinal diseases, and neurological and neuropsychological diseases, among others.
